<DOC>
	<DOC>NCT00227084</DOC>
	<brief_summary>To evaluate whether Arista AH which contains microporous polysaccharides used as a powder applied to the wound area during mammary surgery reduces the amount of bleeding and the duration of surgery. Both mammae are operated on in the same procedure, and one side without Arista serves as control side</brief_summary>
	<brief_title>Effect of Arista Powder on Bleeding in Reductive Mammary Surgery</brief_title>
	<detailed_description>During the operation,before the first incision a randomization envelope is opened. Always starts on the same side, with or without Arista according to the envelope. After surgery, vacuum drains are placed and the amount of drained material and hgb content is measured 24 hours later by nursing staff blinded to what side had Arista.Patients scores postoperative pain with VAS score bilaterally. Three months postoperatively the patients are checked by a physician blinded for what side had Arista</detailed_description>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>All women for mammary hypertrophy day surgery. No exclusions in this group.</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Mammary glands</keyword>
	<keyword>hemostasis</keyword>
	<keyword>Mammaplasty</keyword>
</DOC>